Abingdon Health Plc (AIM: ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX7.75
0.00 (0.00%)
Dec 30, 2024, 4:25 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 29.85 million as of January 2, 2025. Its market cap has increased by 12.21% in one year.
Market Cap
29.85M
Enterprise Value
29.46M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.75
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 29.85M, a decrease of -70.43%. That is a compound annual growth rate of -26.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.28B |
| GSK plc | 54.94B |
| Haleon | 34.17B |
| Smith & Nephew | 8.64B |
| ConvaTec Group | 4.53B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.01B |
| Indivior | 1.29B |